OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Microbiome and spatially resolved metabolomics analysis reveal the anticancer role of gut Akkermansia muciniphila by crosstalk with intratumoral microbiota and reprogramming tumoral metabolism in mice
Zhuxian Zhu, Jixu Cai, Weiwei Hou, et al.
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 53
Zhuxian Zhu, Jixu Cai, Weiwei Hou, et al.
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 53
Showing 1-25 of 53 citing articles:
Bifidobacterium mechanisms of immune modulation and tolerance
Samuel J. Gavzy, Allison Kensiski, Zachariah L Lee, et al.
Gut Microbes (2023) Vol. 15, Iss. 2
Open Access | Times Cited: 67
Samuel J. Gavzy, Allison Kensiski, Zachariah L Lee, et al.
Gut Microbes (2023) Vol. 15, Iss. 2
Open Access | Times Cited: 67
Intratumor microbiota in cancer pathogenesis and immunity: from mechanisms of action to therapeutic opportunities
Man Wang, Fei Yu, Peifeng Li
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 24
Man Wang, Fei Yu, Peifeng Li
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 24
Exploring the gut microbiota and its potential as a biomarker in gliomas
Dana Aljarrah, Naima Chalour, Amine Zorgani, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116420-116420
Open Access | Times Cited: 10
Dana Aljarrah, Naima Chalour, Amine Zorgani, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116420-116420
Open Access | Times Cited: 10
Targeted modulation of gut and intra-tumor microbiota to improve the quality of immune checkpoint inhibitor responses
Weizhou Wang, Junying Fan, Chi Zhang, et al.
Microbiological Research (2024) Vol. 282, pp. 127668-127668
Closed Access | Times Cited: 8
Weizhou Wang, Junying Fan, Chi Zhang, et al.
Microbiological Research (2024) Vol. 282, pp. 127668-127668
Closed Access | Times Cited: 8
The interactions between traditional Chinese medicine and gut microbiota in cancers: Current status and future perspectives
Xuejiao Wei, Fei Wang, Peng Tan, et al.
Pharmacological Research (2024) Vol. 203, pp. 107148-107148
Open Access | Times Cited: 8
Xuejiao Wei, Fei Wang, Peng Tan, et al.
Pharmacological Research (2024) Vol. 203, pp. 107148-107148
Open Access | Times Cited: 8
Fucoidan exerts antitumor effects by regulating gut microbiota and tryptophan metabolism
Pengfei Ren, Meng Liu, Biqian Wei, et al.
International Journal of Biological Macromolecules (2025), pp. 140334-140334
Closed Access | Times Cited: 1
Pengfei Ren, Meng Liu, Biqian Wei, et al.
International Journal of Biological Macromolecules (2025), pp. 140334-140334
Closed Access | Times Cited: 1
Akkermansia muciniphila: A potential target and pending issues for oncotherapy
Xu Zhao, Juanjuan Zhao, Dongmei Li, et al.
Pharmacological Research (2023) Vol. 196, pp. 106916-106916
Open Access | Times Cited: 20
Xu Zhao, Juanjuan Zhao, Dongmei Li, et al.
Pharmacological Research (2023) Vol. 196, pp. 106916-106916
Open Access | Times Cited: 20
Microbiome and lung cancer: carcinogenic mechanisms, early cancer diagnosis, and promising microbial therapies
Weici Liu, Zheshun Pi, Xiaokun Wang, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 196, pp. 104322-104322
Closed Access | Times Cited: 7
Weici Liu, Zheshun Pi, Xiaokun Wang, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 196, pp. 104322-104322
Closed Access | Times Cited: 7
Landscape of tumoral ecosystem for enhanced anti-PD-1 immunotherapy by gut Akkermansia muciniphila
Zhuxian Zhu, Jianguo Huang, Yanling Zhang, et al.
Cell Reports (2024) Vol. 43, Iss. 6, pp. 114306-114306
Open Access | Times Cited: 7
Zhuxian Zhu, Jianguo Huang, Yanling Zhang, et al.
Cell Reports (2024) Vol. 43, Iss. 6, pp. 114306-114306
Open Access | Times Cited: 7
Akkermansia muciniphila-derived pentadecanoic acid enhances oxaliplatin sensitivity in gastric cancer by modulating glycolysis
Qixuan Xu, Jingwang Gao, Ruiyang Zhao, et al.
Pharmacological Research (2024) Vol. 206, pp. 107278-107278
Open Access | Times Cited: 7
Qixuan Xu, Jingwang Gao, Ruiyang Zhao, et al.
Pharmacological Research (2024) Vol. 206, pp. 107278-107278
Open Access | Times Cited: 7
Beyond the Gut: The intratumoral microbiome's influence on tumorigenesis and treatment response
Hao Zhang, Li Fu, Xinwen Leiliang, et al.
Cancer Communications (2024) Vol. 44, Iss. 10, pp. 1130-1167
Open Access | Times Cited: 7
Hao Zhang, Li Fu, Xinwen Leiliang, et al.
Cancer Communications (2024) Vol. 44, Iss. 10, pp. 1130-1167
Open Access | Times Cited: 7
Unveiling the intratumoral microbiota within cancer landscapes
Shusheng Che, Zhiyong Yan, Yugong Feng, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 109893-109893
Open Access | Times Cited: 6
Shusheng Che, Zhiyong Yan, Yugong Feng, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 109893-109893
Open Access | Times Cited: 6
Leveraging the intratumoral microbiota to treat human cancer: are engineered exosomes an effective strategy?
Jie Qiu, Yuancong Jiang, Nanwei Ye, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Jie Qiu, Yuancong Jiang, Nanwei Ye, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Clickable nanozyme enhances precise colonization of probiotics for ameliorating inflammatory bowel disease
Dong Fang, Liangwen Hao, Lin Wang, et al.
Journal of Controlled Release (2024) Vol. 373, pp. 749-765
Open Access | Times Cited: 5
Dong Fang, Liangwen Hao, Lin Wang, et al.
Journal of Controlled Release (2024) Vol. 373, pp. 749-765
Open Access | Times Cited: 5
Akkermansia in the gastrointestinal tract as a modifier of human health
María E. Panzetta, Raphael H. Valdivia
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 5
María E. Panzetta, Raphael H. Valdivia
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 5
The intervention of B. longum metabolites in Fnevs' carcinogenic capacity: A potential double-edged sword
Jingyu Xu, Xiaoxi Xu, Luyi Yang, et al.
Experimental Cell Research (2025), pp. 114407-114407
Closed Access
Jingyu Xu, Xiaoxi Xu, Luyi Yang, et al.
Experimental Cell Research (2025), pp. 114407-114407
Closed Access
Enhancing Biomedicine: Proteomics and Metabolomics in Action
Michele Costanzo, Marianna Caterino, Lucia Santorelli
Proteomes (2025) Vol. 13, Iss. 1, pp. 5-5
Open Access
Michele Costanzo, Marianna Caterino, Lucia Santorelli
Proteomes (2025) Vol. 13, Iss. 1, pp. 5-5
Open Access
THSWD upregulates the LTF/AMPK/mTOR/Becn1 axis and promotes lysosomal autophagy in hepatocellular carcinoma cells by regulating gut flora and metabolic reprogramming
Zhiqin Zhu, Shi Zuo, Zhiqi Zhu, et al.
International Immunopharmacology (2025) Vol. 148, pp. 114091-114091
Open Access
Zhiqin Zhu, Shi Zuo, Zhiqi Zhu, et al.
International Immunopharmacology (2025) Vol. 148, pp. 114091-114091
Open Access
The multipotential effect of microbiome in lung cancer development and progression
Nastaran Karimi, Angélica Baca De Anda, Rachel Yang, et al.
International review of cell and molecular biology (2025)
Closed Access
Nastaran Karimi, Angélica Baca De Anda, Rachel Yang, et al.
International review of cell and molecular biology (2025)
Closed Access
Health Effects and Therapeutic Potential of the Gut Microbe Akkermansia muciniphila
Ezinne Aja, A.-P. Zeng, Weston R. Gray, et al.
Nutrients (2025) Vol. 17, Iss. 3, pp. 562-562
Open Access
Ezinne Aja, A.-P. Zeng, Weston R. Gray, et al.
Nutrients (2025) Vol. 17, Iss. 3, pp. 562-562
Open Access
Disruption of Gut Microbiota and Associated Fecal Metabolites in Collagen-Induced Arthritis Mice During the Early Stage
Dehong Wu, Mengdi Yin, Dandan Cao, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 1703-1717
Open Access
Dehong Wu, Mengdi Yin, Dandan Cao, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 1703-1717
Open Access
Function and therapeutic potential of Amuc_1100, an outer membrane protein of Akkermansia muciniphila: A review
Xuhui Wu, Dahai Yu, Yixuan Ma, et al.
International Journal of Biological Macromolecules (2025), pp. 142442-142442
Closed Access
Xuhui Wu, Dahai Yu, Yixuan Ma, et al.
International Journal of Biological Macromolecules (2025), pp. 142442-142442
Closed Access
Roles of the gut microbiota in hepatocellular carcinoma: from the gut dysbiosis to the intratumoral microbiota
Yiqin Wang, Yongqiang Li, Yong Lin, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
Yiqin Wang, Yongqiang Li, Yong Lin, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
Modulation of gut microbiota: a novel approach to enhancing the effects of immune checkpoint inhibitors
Jinglong Huang, Caifeng Gong, Aiping Zhou
Therapeutic Advances in Medical Oncology (2023) Vol. 15
Open Access | Times Cited: 11
Jinglong Huang, Caifeng Gong, Aiping Zhou
Therapeutic Advances in Medical Oncology (2023) Vol. 15
Open Access | Times Cited: 11
Emerging roles of intratumor microbiota in cancer: tumorigenesis and management strategies
Zhuangzhuang Shi, Zhaoming Li, Mingzhi Zhang
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Zhuangzhuang Shi, Zhaoming Li, Mingzhi Zhang
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
